Sensei Biotherapeutics Inc — Cash Flow (NASDAQ:SNSE) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Cash from operating activities -30.26 M-39.03 M-32.02 M-24.67 M-20.45 M -20.45 M Cash from investing activities -143.12 M49.95 M38.41 M22.44 M19.77 M 19.77 M Cash from financing activities 163.94 M-287 K-11.17 M-787 K-645 K -645 K Free cash flow -32.28 M-39.35 M-32.2 M-24.82 M-20.47 M -20.47 M

Haberler

Sensei Biotherapeutics 17 yeni çalışana hisse opsiyonu verdi

Sensei Biotherapeutics grants stock options to 17 new employees

Sensei Biotherapeutics, Inc. (SNSE) Faeth Therapeutics, Inc. - M&A Call - Slideshow (NASDAQ:SNSE) 2026-02-20

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.26%

Sensei Biotherapeutics hisseleri Faeth Therapeutics satın alımı sonrası fırladı

Sensei Biotherapeutics stock soars after Faeth Therapeutics acquisition

Sensei, Faeth’i satın aldı ve kanser ilacı portföyü için 200 milyon dolar topladı

Sensei acquires Faeth, raises $200 million for cancer drug pipeline

Why Is Sensei Biotherapeutics Stock Skyrocketing Wednesday? - Sensei Biotherapeutics (NASDAQ:SNSE)

Egle Therapeutics appoints John Celebi as CEO to advance autoimmune pipeline

What Sparked Sensei Biotherapeutics (SNSE) Stock's Nearly 63% After‑Hours Jump? - Sensei Biotherapeutics (NASDAQ:SNSE)

Sensei Biotherapeutics hisse senedi notu, şirket kilit ilacı durdurduğu için düşürüldü